Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 185 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Concept Elicitation and Patient Experience Mapping in SA-AKI

Sepsis-associated Acute Kidney Injury United States

CINC424A2X01B Rollover Protocol

Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia, Thalassemia Phase4 South Korea

RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia

HR+/HER2- Early Breast Cancer Saudi Arabia

A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Autoimmune and Chronic Inflammatory Diseases Phase1 United States

NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

Paroxysmal Nocturnal Hemoglobinuria Russia

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Relapsing Multiple Sclerosis Phase3 Australia
Canada
South Africa

Pelacarsen Roll-over Extension Program

Atherosclerotic Cardiovascular Disease Phase3 United States

Long-term Follow up Local Registry Study of Kymriah in South Korea

B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma South Korea

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Coronary Heart Disease Phase4 China

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease Phase3 United States